Nordson MEDICAL Completes Divestiture of Select Contract Manufacturing Products, Narrowing its Focus on Proprietary Medical Components

(NASDAQ:NDSN) WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical. “This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment. This includes our growing portfolio of proprietary medical components, including balloons, cannula, nitinol devices and the recently acquired Atrion produc